Newsfeeds - Spark Newswire

1 minute read

News

NovaBay Pharmaceuticals’ Avenova And DERMAdoctor Products To Be Featured During October 11-12 Amazon Prime Early Access Sale

Today, 9:19 PM

NovaBay® Pharmaceuticals, Inc. (NYSE:NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces that

NBY

3 minute read

NovaBay Pharmaceuticals Receives NYSE American Notice Regarding Low Share Price

By Michael Horton

Today, 9:19 PM

NovaBay® Pharmaceuticals, Inc. (NYSE:NBY) announces that on October 3, 2022 it received a notice from the NYSE American LLC that the Company's common stock has been selling for a low price per share for a

NBY

24 minute read

Options

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

Today, 9:19 PM

On Monday, 429 stocks made new 52-week lows.

ADCT

2 minute read

Why Applied Optoelectronics Is Trading Higher By Around 31%; Here Are 21 Stocks Moving Premarket

By Lisa Levin

Today, 9:19 PM

Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) rose 159.4% to $25.94 in pre-market trading after gaining 11% on Thursday.

AAOI

5 minute read

Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday

By Lisa Levin

Today, 9:19 PM

Gainers Digital Media Solutions, Inc. (NYSE: DMS) shares climbed 71.9% to close at $2.20 on Friday after the company received a non-binding go-private proposal from Prism Data for $2.50 per share in cash.

ADTX

2 minute read

Dow Climbs More Than 400 Points, S&P 500 Rises 1.5%

By Lisa Levin

Today, 9:19 PM

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 400 points on Friday.

ALEC

3 minute read

Options

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

Today, 9:19 PM

During Friday's session, 41 companies made new 52-week lows.

ADV

1 minute read

News

NovaBay Pharmaceuticals Enters Into Agreements For A Private Placement And Warrant Reprice Transactions To Raise Up To $5.3M

By Bill Haddad

Today, 9:19 PM

NovaBay® Pharmaceuticals, Inc. (NYSE:NBY) ("NovaBay" or the "Company") announces it has entered into a Securities Purchase Agreement with certain institutional investors in connection with a

NBY

1 minute read

Earnings

Recap: NovaBay Pharmaceuticals Q2 Earnings

By Benzinga Insights

Today, 9:19 PM

NovaBay Pharmaceuticals (AMEX:NBY) reported its Q2 earnings results on Thursday, August 11, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

NBY

1 minute read

NovaBay Pharmaceuticals Q2 EPS $(0.04) Misses $(0.03) Estimate, Sales $3.04M Miss $3.51M Estimate

By Michael Horton

Today, 9:19 PM

NovaBay Pharmaceuticals (AMEX:NBY) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 33.33 percent. This is unchanged from the same period last year. The company

NBY